Presenting With Magic

  In part three of our series on Presentation Skills we will be looking at ways to communicate and...

PCTs – Mission impossible for 2003?

SO WHAT IS IT that will be keeping PCTs, their Chief Executive’s and other members of the team awake at nights? This table gives...

Breathing in, and Breathing out: Pulmonary Drug Delivery Technologies

Although Millions of people depend on injectable medications for treatment of various ailments, none of them enjoy this experience. The pain, trauma and anguish...

The Strategy of Change

     I have chosen this subject because I would be very surprised if you have not already had considerable...

Latest articles

Maxwellia makes two new appointments

Maxwellia expand their team with two new appointments

Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator. 
BMS & Boston Medical Center enter collaboration

BMS & Boston Medical Center announce research collaboration

BMS & Boston Medical Center enter research collaboration to investigate markers of immuno-oncology response and resistance Bristol-Myers Squibb Company...
Syringe with liquid

EC approves KEYTRUDA® as adjuvant therapy

MSD (Merck in the U.S. and Canada) has announced that the European Commission has approved its anti-PD-1 therapy, KEYTRUDA (pembrolizumab), for the adjuvant treatment...